1 / 4

CDER Common Data Standards Issues Document

CDER Common Data Standards Issues Document. Motivation CDISC submissions received varied more than expected Contents Current FDA‘s preferences/recommendation for SDTM/ADaM More guidance on SDTM implementation than ADaM DIA Webinar with CDER And CBER representatives Mainly Q&A

dezso
Télécharger la présentation

CDER Common Data Standards Issues Document

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CDER Common Data Standards Issues Document • Motivation • CDISC submissions received varied more than expected • Contents • Current FDA‘s preferences/recommendation for SDTM/ADaM • More guidance on SDTM implementation than ADaM • DIA Webinar with CDER And CBER representatives • Mainly Q&A • More answers on SDTM than on ADaM • Document is under Revision • to be updated periodically

  2. Key Messages • SDTM is best considered early • Just legacy conversion of raw data to SDTM is not good enough • Ensure traceability between data and results • ADaM ADSL is considered mandatory • Provide a define.pdf along with the define.xml • some reviewers insist that the data definition document should be printable • Discuss with FDA specific submission requirements

  3. Document Walk-through • CDER Common Data Standards Issues Document Marked.pdf

  4. Points for Discussion • What do you do in your current projects? • Implement Draft Amendment to SDTM V1.2? • No/Yes/Parts of it and Why? • Implement other Recommendations? Any changes needed? • define.xml + define.pdf? • EPOCH, ELEMENT, ETCD? • Dictionary Versions (e.g., MedDRA)? • Splitting of (SDTM) Datasets? What to submit and document in define? • --BLFL, --DY, --STDY, --ENDY? • Process to ensure traceability in legacy conversion projects? • ADaM implementation? If yes, source for ADaM? • Define schema validation? • Did you submit comments to the FDA? • Any recent experiences with FDA?

More Related